These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002811-98 Randomised phase II study of cetuximab in combination with gemcitabine or gemcitabine followed by cetuximab in patients with advanced non-small-cell lung cancer, not suitable for standard platin-based... not-yet-due
Listed as ongoing, but also has a completion date 2004-004456-39 A Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients with Epithelial Ovarian Ca... 2012-06-01 bad-data
Completed, but no date Terminated 2005-005631-97 CAPPA-2 (PS-2) bad-data
Ongoing 2005-005968-90 An international multicenter randomized phase III study of first-line Erlotinib followed by second-line Cisplatin Gemcitabine versus first-line Cisplatin Gemcitabine followed by second-line Erlot... not-yet-due
Exempt 2006-000426-31 STUDIO DI FASE I DELLA COMBINAZIONE FARMACOLOGICA TRA ACIDO ZOLEDRONICO E DOCETAXEL IN PAZIENTI CON CARCINOMA PROSTATICO METASTATICO ORMONO - REFRATTARIO not-yet-due
Ongoing 2006-001724-40 Phase II study with capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer not-yet-due
Ongoing 2006-003243-23 A Phase II Study of OXALIPLATIN and GEMCITABINE in Combination with IFOSFAMIDE plus RITUXIMAB not-yet-due
Completed, but no date Terminated 2006-003993-85 Phase II Study of neoadjuvant therapy with trastuzumab plus docetaxel followed by trastuzumab plus pegylated liposomal doxorubicin and cyclophosphamide in human ErbB-2-positive operable or locally adv... bad-data
Ongoing 2006-003994-28 VINORELBINE, CARBOPLATIN AND TRASTUZUMAB IN ADVANCED HER-2 POSITIVE BREAST CANCER. A PHASE 2 STUDY not-yet-due
Completed, but no date 2006-003995-36 A MULTICENTER RANDOMIZED PHASE III STUDY COMPARING FIXED DOSES WITH TOXICITY-ADJUSTED DOSES OF STANDARD CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY ADVANCED SMALL CELL LUNG CANCE... bad-data
Ongoing 2008-001754-40 WEEKLY vs EVERY 3 WEEK CARBOPLATIN + PACLITAXEL IN PATIENTS WITH OVARIAN CANCER: RANDOMIZED MULTICENTER STUDY not-yet-due
Ongoing 2008-001755-22 Stealth liposomal doxorubicin vs carboplatin/paclitaxel in patients with ovarian cancer recurrence between six and twelve months after previous platinum based chemotherapy: phase III multicenter rando... not-yet-due
Completed, but no date 2008-005307-26 Intratecal Ziconotide in the treatment of neuropatic pain in cancer patients. A phase II study. bad-data
Ongoing 2009-010099-74 A RANDOMIZED PHASE II STUDY OF CARBOPLATIN AND PACLITAXEL +/- CETUXIMAB, IN ADVANCED AND/OR RECURRENT CERVICAL CANCER not-yet-due
Ongoing 2009-013540-36 The MILES-3 randomized phase III study assessing the efficacy of cisplatin combined with gemcitabine as first-line therapy of elderly patients with advanced non small cell lung cancer. not-yet-due
Ongoing 2009-013870-42 Sorafenib in the first line treatment of advanced hepatocellular carcinoma with ChildPugh liver function class B. Multicentre phase 3 randomized trial not-yet-due
Completed, but no date 2009-016151-21 A randomized multicentre phase II trial with pazopanib and weekly paclitaxel vs weekly paclitaxel in platinum resistant or refractory ovarian cancer bad-data
Ongoing 2010-018363-42 A phase II dose finding study of induction cisplatin, docetaxel and escalating doses of capecitabine followed by concurrent cetuximab and radiotherapy in locally advanced inoperable head and neck squa... not-yet-due
Ongoing 2010-018581-23 CONSERVATIVE MANAGEMENT OF ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA not-yet-due
Ongoing 2010-024490-39 A phase 2 study of panitumumab in patients with not-yet-due
Ongoing 2011-000587-10 SODIUM PICOSULPHATE AND MAGNESIUM CITRATE VERSUS POLYETHYLENE GLYCOLE (PEG) AS EVACUATING TREATMENT PRIOR TO COLONOSCOPY: not-yet-due
Ongoing 2011-001739-21 A study of Sativex for pain Relief and appetite stimulation in Patients with advanced malignancy. Phase II not-yet-due
Ongoing 2011-002810-35 A Phase 1/2 Study of Lenalidomide in combination with Bendamustine (LEBEN) in relapsed and primary refractory Hodgkin Lymphoma not-yet-due
Ongoing 2011-004997-27 Randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer not-yet-due
Completed, but no date Terminated 2011-006097-76 RANDOMIZED PHASE 3 TRIAL EVALUATING THE EFFICACY OF LOCOREGIONAL TREATMENT WITH TRANSARTERIAL EMBOLIZATION (TAE) FOR LIVER METASTASIS, IN COMBINATION WITH OCTREOTIDE LAR, IN PATIENTS WITH NEUROENDOCRI... bad-data
Ongoing 2012-000164-25 A factorial study comparing pemetrexed with gemcitabine and testing the efficacy of the addition of cisplatin in elderly patients with non squamous advanced, metastatic or recurrent NSCLC. not-yet-due
Ongoing 2012-003043-29 A multicenter study in patients with stage III-IV epithelial ovarian cancer treated with carboplatin/paclitaxel with bevacizumab: clinical and biological prognostic factors not-yet-due
Listed as ongoing, but also has a completion date 2012-004362-17 A multicenter phase III randomized study with second line chemotherapy plus or minus bevacizumab in patients with platinum sensitive epithelial ovarian cancer recurrence after a bevacizumab/chemothera... 2018-01-08 bad-data
Completed, but no date Terminated 2013-001630-18 Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction. bad-data
Completed, but no date Terminated 2013-002074-46 Multicentre, two-stage, phase 2 study of neoadjuvant FOLFIRINOX followed by chemo-IMRT in patients with locally advanced unresectable pancreatic cancer bad-data
Ongoing 2014-001523-69 Preclinical and clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of head and neck not-yet-due
Exempt 2015-003389-10 A phase I/II trial of IMA970A plus CV8102 following a single pre-vaccination infusion of cyclophosphamide in patients with very early, early and intermediate stage of hepatocellular carcinoma after an... 2019-12-20 not-yet-due
Ongoing 2018-003589-15 Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial not-yet-due
Ongoing 2018-003778-29 Phase II study on the use of the FOLFIRI + Cetuximab association in the first-line treatment of patients with advanced colorectal carcinoma with wild type RAS and FcYRIIIA-V / V not-yet-due
Ongoing 2018-003925-27 Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer not-yet-due
Ongoing 2018-004166-33 ORGAN SPARING FOR LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT FOLLOWED BY ELECTROCHEMOTHERAPY not-yet-due
Ongoing 2020-001110-38 Multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia not-yet-due